3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Leukemia
19
Leukemia, Myelomonocytic, Acute
11
Leukemia, Monocytic, Acute
10
Leukemia, Erythroblastic, Acute
9
Congenital Abnormalities
8
Leukemia, Megakaryoblastic, Acute
7
Burkitt Lymphoma
6
Myelodysplastic Syndromes
4
Leukemia, Eosinophilic, Acute
4
Myeloproliferative Disorders
3
Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Leukemia, Basophilic, Acute
3
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Hematologic Neoplasms
2
Thrombocytopenia
1
Thrombocythemia, Essential
1
Sarcoma, Myeloid
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Immunoproliferative Disorders
1
Interventions
Imatinib Mesylate
6
Cytarabine
5
ponatinib
4
nilotinib
4
venetoclax
3
fludarabine phosphate
3
Mycophenolic Acid
3
thymoglobulin
2
fludarabine
2
enasidenib
2
Methotrexate
2
Lenalidomide
2
Cyclosporine
2
Cyclophosphamide
2
Azacitidine
2
Antilymphocyte Serum
2
quizartinib
1
methanesulfonic acid
1
glasdegib
1
etoposide phosphate
1
daratumumab
1
bosutinib
1
asciminib
1
Whole-Body Irradiation
1
Transplantation
1
Temozolomide
1
Tacrolimus
1
Stem Cell Transplantation
1
Standard of Care
1
RFT5-SMPT-dgA immunotoxin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid
×
Daunorubicin
×
Clear all
No trials found.